Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01448915 · ClinicalTrials.gov registry record
Management of Hepatitis C in HIV Infected Injection Drug Users (IDUs)
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 828
- Enrollment target
NCT01448915: Completed study, sponsored by Johns Hopkins University.
NCT01448915 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 828 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01448915 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 828 participants
- Enrollment target
Study Summary
The principal goal of this research project is to evaluate the natural history of HCV and liver disease and its treatment in HIV-infected persons who use drugs. Research procedures will focus on determining liver disease prevalence and severity within this population. This is an observational study without study specific interventions.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 828 participants |
| Start Date | 2021-03-31 |
| Est. Completion | 2021-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01448915
The ClinicalTrials.gov registry entry for NCT01448915 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 828 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01448915 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01448915 about?
NCT01448915 is a clinical study titled "Management of Hepatitis C in HIV Infected Injection Drug Users (IDUs)". The principal goal of this research project is to evaluate the natural history of HCV and liver disease and its treatment in HIV-infected persons who use drugs. Research procedures will focus on determining liver disease prevalence and severity within this population. This is an observational study ...
What is the current status of trial NCT01448915?
This trial is currently completed. The enrollment target is 828 participants. The study started on 2021-03-31. Estimated completion is 2021-03-31.
Who is sponsoring clinical trial NCT01448915?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.